CONFLICTS OF INTEREST IN SPONSORED RESEARCH June 26-29, 2002 Susan H. Ehringhaus The University of North Carolina at Chapel Hill Chapel Hill, North Carolina Institutional Conflicts of Interest I. II. “Early” Efforts (mid 1990’s) A. "Equity" Policies (Harvard, MIT, Iowa, and others) B. Individual COI Policies as applicable to those in administrative roles and to governing boards; sometimes viewed as "institutional" C. State COI Statutes -- applicable to governing boards and senior executives in public institutions D. Commentary 1. Debate between self policing vs. external regulation 2. NEJM 332:262-268 (January 26, 1995): (a) Clinical research/licensing agreement (b) Framework for analysis i. Relation between institution’s primary missions and its financial interest ii. Size of financial interest iii. Degree of discretion involved in achieving the primary missions iv. Seriousness of the harms that might result from the institutional COI (patient care, teaching, research) (c) Safeguards against harm from institutional COI i. Disclosure ii. Internal monitoring iii. External monitoring (d) Additional regulation of institutional COI i. No reliable data to evaluate incidence ii. Necessary to evaluate benefits/burdens of additional regulation before implementation AAU Task Force on Research Accountability’s Report on Individual and Institutional Financial Conflicts of Interest (October 2001) National Association of College and University Attorneys 1 A. Definition of Institutional COI “An institutional financial conflict of interest may occur when the institution, any of its senior management or trustees, or a department, school, or other sub-unit, or an affiliated foundation or organization, has an external relationship or financial interest in a company that itself has a financial interest in a faculty research project.” 1. Categories of such conflicts: --conflicts involving university equity holdings or royalty arrangements and research programs; -- conflicts involving university officials who make decisions with institution-wide implications (governing board members, presidents, chancellors, deans, department heads and leaders of laboratories. (These include conflicts between an individual’s personal financial holdings and their institutional responsibilities; and conflicts between the individual's responsibilities in a fiduciary or management role of an entity with a business relationship with the institution and his/her responsbilities to the institution.) “A related situation involves senior university officers who serve on governmentappointed boards. Where these boards involve federal or state agencies which provide research funds to the university, the university official must navigate between the potential clash of interests between the university and the government agency involved.” B. Addressing Potential Institutional COI “a. “b. “c. disclose always; manage the conflict in most cases; prohibit the activity when necessary to protect the public interest or the interest of the university. Segregation of decision making about the financial activities and the research activities, so that they are separately and independently managed C. Steps to Consider 1. 2. 3. 4. 5. 6. 7. 8. D. Develop and publicize clear policies Establish administrative processes Establish a review group on institutional COI Disclose potential conflicts to review group Use review group to assess potential conflicts, weigh risks and benefits Take action regarding institutional conflicts Strictly scrutinize institutional conflicts involving humans Strictly scrutinize equity that is not liquid or is less liquid Methods of Dealing with Institutional Conflicts National Association of College and University Attorneys 2 “a. “b. “c. “d. III. not conducting proposed research at that institution, or halting it if it has commenced; reducing or otherwise modifying the financial (equity or royalty) stake involved; increasing the segregation between the decision-making regarding the financial and the research activities; and establishing a research monitoring process, so that the research can be closely scrutinized to ensure that potential conflicts do not undermine the integrity of the work (and of the university).” GAO Report to Senator Bill Frist, Subcommittee on Public Health, Committee on Health, Education, Labor, and Pensions; U.S. Senate “Biomedical Research: HHS Direction Needed to Address Financial Conflicts of Interest” November 2001 (GAO-02-89: Financial Conflicts in Biomedical Research) IV. A. Focused almost exclusively on individual COI B. Institutional COI 1. Although not required, universities had policies and procedures that addressed aspects of institutional financial COIs. 2. Universities managed institutional investments separately from academic units 3. Some universities tried to minimize potential for institutional conflicts by separating the Technology Transfer Office from Academic Affairs 4. Universities placed limits on their equity holdings and roles in start-up companies. AAMC Task Force on Financial Conflicts of Interest in Clinical Research Individual conflicts report issued December, 2001. Institutional conflicts report in preparation. V. Common Themes A. Interests at Stake 1. 2. 3. 4. 5. 6. B. Integrity of university Research objectivity Fiscal responsibility Independence of IRB and IACUC review Research compliance Primacy of interests of human subjects, where applicable Key Principles to Observe 1. Accountable separation of responsibility (a) Research (b) Compliance National Association of College and University Attorneys 3 (c) (d) 2. C. D. Financial The closer the proximity to research, the more absolute the firewall needed External credibility (a) Review by persons from outside university (b) Transparency Key Processes Necessary 1. Clear assignment of institutional responsibility 2. Interactive, searchable databases (a) Donors (b) Research sponsors (c) Inventors (d) Start-ups (e) IRB (f) IACUC (g) Equity holdings not in endowment (h) Licensees 3. Review committees (a) Advisory vs. decision making (b) Outside members (c) Disclosure? (d) BOT? Workable Review Mechanisms potential for institutional COI degree of scrutiny (burden on the process vs. yield rate of serious conflicts) * 1. 2. 3. 4. 5. Equity in a start-up sponsoring research at the institution Major research contracts over x years from one sponsor Major gifts over x years from a research sponsor Patent royalties from licensee who sponsors research Endowment position and licensee or research National Association of College and University Attorneys 4 * types of potentially compromising events 6. E. Venture activity and research Institutional Response to Institutional COI 1. 2. 3. 4. 5. 6. 7. 8. Not doing research External monitoring via review group Internal monitoring Modifying or giving up financial interest Increasing segregation between financial interest and research Recusal of senior officials External IRB review Multi-center clinical trials National Association of College and University Attorneys 5